A detailed history of Intrust Bank Na transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Intrust Bank Na holds 2,826 shares of NBIX stock, worth $353,250. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,826
Previous 2,854 0.98%
Holding current value
$353,250
Previous $392,000 17.09%
% of portfolio
0.03%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$114.58 - $153.15 $3,208 - $4,288
-28 Reduced 0.98%
2,826 $325,000
Q2 2024

Aug 08, 2024

SELL
$130.86 - $143.19 $9,683 - $10,596
-74 Reduced 2.53%
2,854 $392,000
Q1 2024

May 09, 2024

SELL
$130.4 - $143.74 $6,389 - $7,043
-49 Reduced 1.65%
2,928 $403,000
Q4 2023

Feb 05, 2024

SELL
$106.07 - $132.76 $72,764 - $91,073
-686 Reduced 18.73%
2,977 $392,000
Q3 2023

Nov 13, 2023

SELL
$94.02 - $117.1 $119,405 - $148,717
-1,270 Reduced 25.74%
3,663 $412,000
Q2 2023

Aug 10, 2023

SELL
$89.53 - $104.87 $32,409 - $37,962
-362 Reduced 6.84%
4,933 $465,000
Q1 2023

May 04, 2023

SELL
$94.11 - $123.02 $45,737 - $59,787
-486 Reduced 8.41%
5,295 $535,000
Q4 2022

Feb 10, 2023

BUY
$106.72 - $127.06 $31,909 - $37,990
299 Added 5.45%
5,781 $690,000
Q3 2022

Nov 09, 2022

BUY
$92.03 - $107.81 $47,763 - $55,953
519 Added 10.46%
5,482 $582,000
Q2 2022

Aug 16, 2022

SELL
$75.79 - $100.07 $96,783 - $127,789
-1,277 Reduced 20.46%
4,963 $484,000
Q1 2022

May 10, 2022

BUY
$72.45 - $94.81 $243,069 - $318,087
3,355 Added 116.29%
6,240 $585,000
Q4 2021

Feb 03, 2022

SELL
$79.65 - $106.22 $77,499 - $103,352
-973 Reduced 25.22%
2,885 $246,000
Q3 2021

Nov 04, 2021

BUY
$86.18 - $99.03 $34,472 - $39,612
400 Added 11.57%
3,858 $370,000
Q2 2021

Aug 05, 2021

BUY
$89.43 - $102.27 $115,454 - $132,030
1,291 Added 59.58%
3,458 $336,000
Q1 2021

Jun 02, 2021

BUY
$87.57 - $119.4 $189,764 - $258,739
2,167 New
2,167 $211,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.